Iris pigment epithelial cell translocation in exudative age-related macular degeneration A pilot study in patients

被引:0
|
作者
A. Lappas
A. W. A. Weinberger
A. M. H. Foerster
T. Kube
K. A. Rezai
B. Kirchhof
机构
[1] Augenklinik,
[2] Universitätsklinikum der RWTH Aachen,undefined
[3] Pauwelsstrasse 30,undefined
[4] 52057 Aachen,undefined
[5] Germany e-mail: alappas@post.klinikum.rwth-aachen.de Tel.:+49–241-8088191 Fax:+49–0241–8888408,undefined
[6] Department of Ophthalmology and Visual Science,undefined
[7] University of Chicago,undefined
[8] 939 E. 57th Street,undefined
[9] Chicago,undefined
[10] IL 60637,undefined
[11] USA,undefined
关键词
Choroidal Neovascularization; Subretinal Space; Macular Function; Fluorescence Angiography; Preoperative Visual Acuity;
D O I
暂无
中图分类号
学科分类号
摘要
Background: This prospective, non-controlled pilot study investigates the practicability of IPE translocation and functional outcome in ARMD patients. Removal of submacular choroidal neovascularization (CNV) in age-related macular degeneration (ARMD) is usually associated with RPE damage and poor visual prognosis. Homologous RPE transplants fail to preserve macular function, possibly due to immune rejection. Instead of homologous RPE, we suggest translocating autologous iris pigment epithelium (IPE), building on earlier evidence from animal and in vitro investigations that IPE can substitute RPE functions in the experimental animal. Immunological cell rejection is avoided. Methods: Four eyes with well- defined and eight eyes with ill- defined subfoveal CNV were submitted to operation and followed up for a minimum of 6 months. IPE cells were harvested from a peripheral iridectomy. A vitrectomy was performed. Submacular membranes were removed, and isolated IPE cells were injected into the subretinal space. Examinations included ETDRS visual acuity, fluorescein angiography, and SLO microperimetry. Results: All patients underwent successful surgical removal of CNV and subretinal IPE injection. Compared to preoperative visual acuity (20/400–20/100) no significant change was observed after 6 months (20/320–16/80). A change of more than two ETDRS chart lines was defined as significant. One eye with preoperative ill-defined CNV developed a recurrence, leading to reduced visual acuity. In all patients, postoperative fluorescence angiography revealed early hyperfluorescence (window defect) in the surgically denuded area. Central fixation was demonstrated in 50% of eyes. Conclusions: Preliminary data suggests that IPE translocation in submacular surgery for ARMD can preserve but not improve preoperative visual acuity over 6 months. Functional results are promising compared to submacular membrane extraction alone and RPE transplantation. Continued research on improvement of IPE translocation seems justified.
引用
收藏
页码:631 / 641
页数:10
相关论文
共 50 条
  • [31] Translocation of autologous retinal pigment epithelium and choroid in patients with exudative age-related macular degeneration: further follow-up.
    Van Meurs, JC
    Maaijwee, K
    van den Biesser, PR
    Vijfvinkel, G
    Croxen, R
    van Hagen, M
    Hofland, L
    Baarsma, GS
    Joussen, A
    Kirchhof, B
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U484 - U484
  • [32] Pilot study of intravitreal injection of triamcinolone acetonide in exudative age-related macular degeneration
    Moon, SJ
    Mieler, WF
    Holz, ER
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U279 - U279
  • [33] Foveal translocation for exudative age related macular degeneration
    McLeod, D
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (04) : 344 - 345
  • [34] Drusen in Exudative Age-Related Macular Degeneration
    Yu, S. -Y.
    Cho, N. -S.
    Kim, M. -S.
    Kim, E. -S.
    Kwak, H. -W.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [35] Underdiagnosis of glaucoma in patients with exudative age-related macular degeneration
    Mergen, Burak
    Ramsey, David J.
    EYE, 2021, 35 (12) : 3350 - 3357
  • [36] Treatment of Exudative Age-Related Macular Degeneration
    Jo, Nam Chun
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2007, 50 (08): : 731 - 735
  • [37] Pegaptanib in exudative age-related macular degeneration
    Amoaku, WM
    DRUGS, 2005, 65 (11) : 1579 - 1579
  • [38] PegaptanibIn Exudative Age-Related Macular Degeneration
    M. Asif A. Siddiqui
    Gillian M. Keating
    Drugs, 2005, 65 : 1571 - 1577
  • [39] Angiographic findings in patients with exudative age-related macular degeneration
    Jochen Bermig
    Hans Tylla
    Claudia Jochmann
    Andrei Nestler
    Sebastian Wolf
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2002, 240 : 169 - 175
  • [40] Angiographic findings in patients with exudative age-related macular degeneration
    Bermig, J
    Tylla, H
    Jochmann, C
    Nestler, A
    Wolf, S
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2002, 240 (03) : 169 - 175